Literature DB >> 28422121

A decrease in blood cholesterol after gastrostomy could impact survival in ALS.

H Blasco1,2, F Patin1,2, S Molinier2, P Vourc'h1,2, O Le Tilly2, S Bakkouche3, C R Andres1,2, V Meininger3, P Couratier3,4, P Corcia1,3.   

Abstract

Although the global benefits of gastrostomy have been proven in amyotrophic lateral sclerosis (ALS), the impact on biological parameters has not been explored yet. The aim of this preliminary work was to evaluate the modification of biological parameters in patients with ALS undergoing gastrostomy. We retrospectively collected clinical and biological data from 44 patients having undergone gastrostomy at three time points (T0, T1 and T2: before, at the time of and after gastrostomy). We examined the relationship between the biological parameters and disease progression. Variations of the concentrations of total cholesterol significantly differed before (T1-T0) vs those after gastrostomy (T2-T1; P=0.0044). The variations of total cholesterol and low-density lipoprotein cholesterol concentrations after gastrostomy were negatively associated with survival (P=0.0002). This study showed for the first time that patients with ALS fed quite exclusively by gastrostomy had decreased blood cholesterol after gastrostomy. We suggest that a restoration of normal lipid metabolism should be planned in patients with ALS.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28422121     DOI: 10.1038/ejcn.2017.54

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  9 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

2.  Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study.

Authors:  Johannes Dorst; Luc Dupuis; Susanne Petri; Katja Kollewe; Susanne Abdulla; Joachim Wolf; Markus Weber; David Czell; Christian Burkhardt; Frank Hanisch; Stefan Vielhaber; Thomas Meyer; Gabriele Frisch; Dagmar Kettemann; Torsten Grehl; Bertold Schrank; Albert C Ludolph
Journal:  J Neurol       Date:  2015-01-25       Impact factor: 4.849

Review 3.  The serum lipid profiles of amyotrophic lateral sclerosis patients: A study from south-west China and a meta-analysis.

Authors:  Rui Huang; Xiaoyan Guo; Xueping Chen; Zhenzhen Zheng; Qianqian Wei; Bei Cao; Yan Zeng; Huifang Shang
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-06-29       Impact factor: 4.092

4.  Effect of lipid profile on prognosis in the patients with amyotrophic lateral sclerosis: Insights from the olesoxime clinical trial.

Authors:  Muhammad K Rafiq; Ellen Lee; Michael Bradburn; Christopher J McDermott; Pamela J Shaw
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-07-10       Impact factor: 4.092

5.  Validation of bioelectrical impedance analysis in patients with amyotrophic lateral sclerosis.

Authors:  Jean C Desport; Pierre M Preux; Corinne Bouteloup-Demange; Pierre Clavelou; Bernard Beaufrère; Christine Bonnet; Philippe P Couratier
Journal:  Am J Clin Nutr       Date:  2003-05       Impact factor: 7.045

6.  Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial.

Authors:  Anne-Marie Wills; Jane Hubbard; Eric A Macklin; Jonathan Glass; Rup Tandan; Ericka P Simpson; Benjamin Brooks; Deborah Gelinas; Hiroshi Mitsumoto; Tahseen Mozaffar; Gregory P Hanes; Shafeeq S Ladha; Terry Heiman-Patterson; Jonathan Katz; Jau-Shin Lou; Katy Mahoney; Daniela Grasso; Robert Lawson; Hong Yu; Merit Cudkowicz
Journal:  Lancet       Date:  2014-02-28       Impact factor: 79.321

7.  Enteral feeding through endoscopic gastrostomy in amyotrophic lateral sclerosis patients.

Authors:  Gonçalo Nunes; Carla Adriana Santos; Miguel Grunho; Jorge Fonseca
Journal:  Nutr Hosp       Date:  2016-09-20       Impact factor: 1.057

Review 8.  Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R G Miller; C E Jackson; E J Kasarskis; J D England; D Forshew; W Johnston; S Kalra; J S Katz; H Mitsumoto; J Rosenfeld; C Shoesmith; M J Strong; S C Woolley
Journal:  Neurology       Date:  2009-10-13       Impact factor: 9.910

9.  Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.

Authors:  L Dupuis; P Corcia; A Fergani; J-L Gonzalez De Aguilar; D Bonnefont-Rousselot; R Bittar; D Seilhean; J-J Hauw; L Lacomblez; J-P Loeffler; V Meininger
Journal:  Neurology       Date:  2008-01-16       Impact factor: 9.910

  9 in total
  2 in total

Review 1.  How Can a Ketogenic Diet Improve Motor Function?

Authors:  Charlotte Veyrat-Durebex; Pascal Reynier; Vincent Procaccio; Rudolf Hergesheimer; Philippe Corcia; Christian R Andres; Hélène Blasco
Journal:  Front Mol Neurosci       Date:  2018-01-26       Impact factor: 5.639

Review 2.  The effects of diet and sex in amyotrophic lateral sclerosis.

Authors:  J A Pape; J H Grose
Journal:  Rev Neurol (Paris)       Date:  2020-03-05       Impact factor: 2.607

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.